Tiziana Life Sciences Ltd (TLSA) has a negative trailing P/E of -4.1, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -24.41%.
Criteria proven by this page:
Overall SharesGrow Score: 40/100 with 1/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2015 | -15.3 | 0.22 | 15.57 | 0.00 | - |
| 2016 | -24.9 | 0.94 | 54.23 | 0.00 | - |
| 2017 | -26.7 | 1.84 | -107.27 | 0.00 | - |
| 2018 | -31.6 | 1.56 | 486.52 | 0.00 | - |
| 2019 | -25.2 | -1.60 | -44.08 | 0.00 | - |
| 2020 | -3.8 | -0.01 | 2.15 | 0.00 | - |
| 2021 | -2.0 | 0.18 | 1.14 | 0.00 | - |
| 2022 | -2.0 | 0.05 | 1.56 | 0.00 | - |
| 2023 | -1.6 | -0.12 | 5.14 | 0.00 | - |
| 2024 | -3.1 | 0.09 | 9.43 | 0.00 | - |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2015 | $-0.18 | $0.00 | $-8.63M | - |
| 2016 | $-0.14 | $0.00 | $-7.21M | - |
| 2017 | $-0.12 | $0.00 | $-6.77M | - |
| 2018 | $-0.09 | $0.00 | $-6.3M | - |
| 2019 | $-0.11 | $0.00 | $-7.31M | - |
| 2020 | $-0.54 | $0.00 | $-26.13M | - |
| 2021 | $-0.48 | $0.00 | $-23.42M | - |
| 2022 | $-0.30 | $0.00 | $-15.4M | - |
| 2023 | $-0.34 | $0.00 | $-17.69M | - |
| 2024 | $-0.22 | $0.00 | $-11.86M | - |
| Year | EPS (Avg) | EPS Range | Revenue (Avg) | Revenue Range | Analysts |
|---|---|---|---|---|---|
| 2026 | $-0.20 | $-0.20 – $-0.20 | $0.00 | $0.00 – $0.00 | 1 |
